Victory Capital Management Inc Clovis Oncology, Inc. Transaction History

Victory Capital Management Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$1.05 - $2.85 $3,071 - $8,336	-2,925 Reduced 15.39%	16,075 $19,000
Q2 2022 Aug 01, 2022	BUY	$0.63 - $2.96 $55 - $260	88 Added 0.47%	19,000 $34,000
Q1 2022 May 04, 2022	BUY	$1.43 - $3.14 $1,627 - $3,573	1,138 Added 6.4%	18,912 $38,000
Q4 2021 Feb 07, 2022	BUY	$2.7 - $4.76 $2,910 - $5,131	1,078 Added 6.46%	17,774 $48,000
Q3 2021 Nov 02, 2021	BUY	$4.06 - $5.8 $5,570 - $7,957	1,372 Added 8.95%	16,696 $74,000
Q2 2021 Aug 03, 2021	SELL	$5.02 - $7.05 $3,212 - $4,512	-640 Reduced 4.01%	15,324 $89,000
Q1 2021 May 04, 2021	BUY	$4.81 - $10.34 $9,889 - $21,259	2,056 Added 14.78%	15,964 $112,000
Q4 2020 Feb 01, 2021	BUY	$4.13 - $6.41 $3,006 - $4,666	728 Added 5.52%	13,908 $67,000
Q3 2020 Nov 09, 2020	BUY	$4.82 - $7.72 $776 - $1,242	161 Added 1.24%	13,180 $77,000
Q2 2020 Aug 07, 2020	BUY	$5.69 - $9.69 $11,818 - $20,126	2,077 Added 18.98%	13,019 $88,000
Q1 2020 May 04, 2020	SELL	$3.77 - $11.0 $437 - $1,276	-116 Reduced 1.05%	10,942 $70,000
Q4 2019 Feb 04, 2020	BUY	$3.0 - $16.43 $6,546 - $35,850	2,182 Added 24.58%	11,058 $92,000
Q3 2019 Nov 12, 2019	BUY	$3.93 - $15.35 $34,882 - $136,246	8,876 New	8,876 $35,000
Q3 2018 Nov 01, 2018	SELL	$29.37 - $49.48 $5,550 - $9,351	-189 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$42.06 - $62.4 $607,346 - $901,056	-14,440 Reduced 98.71%	189 $9,000
Q1 2018 May 04, 2018	BUY	$50.12 - $67.72 $723,732 - $977,876	14,440 Added 7640.21%	14,629 $772,000
Q2 2017 Aug 07, 2017	BUY	N/A	189	189 $18,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.